Earth Life Sciences Inc.

CLTS

US27032P2083

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 14:30:05 06/06/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2022	Earth Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
2022	Earth Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI

Earth Life Sciences Inc. (OTCPK : CLTS) signed an agreement to acquire VIVA Health, Inc.

October 03, 2021

Earth Life Sciences Inc. (OTCPK : CLTS) signed an agreement to acquire VIVA Health, Inc. on October 4, 2021. The company plans to change its name to VIVA USA.

Latest news about Earth Life Sciences Inc.

Earth Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/12/22	CI
Earth Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	29/08/22	CI
Earth Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Earth Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/04/22	CI
Earth Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/11/21	CI
Earth Life Sciences Inc. (OTCPK : CLTS) signed an agreement to acquire VIVA Health HK Limited for £18.1 million.	03/10/21	CI
Earth Life Sciences Inc. (OTCPK : CLTS) signed an agreement to acquire VIVA Health, Inc.	03/10/21	CI
Earth Life Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	16/08/21	CI
Earth Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/05/21	CI
Earth Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	05/05/21	CI
Earth Life Sciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	16/11/20	CI
Earth Life Sciences Inc Reports Earnings Results for the Second Quarter Ended June 30, 2020	14/08/20	CI
Earth Life Sciences Inc Reports Earnings Results for the First Quarter Ended March 31, 2020	02/06/20	CI
Earth Life Sciences Inc Reports Earnings Results for the Full Year Ended December 31, 2019	17/03/20	CI
Earth Life Sciences To Seek Acquisitions	18/12/18	CI
Earth Life Sciences Inc to Establish New Division to Acquire Nutraceutical Companyies	30/06/16	CI
Earth Life Sciences Seeks Acquisitions	17/06/16	CI
Earth Life Sciences Inc. Announces Extensive Marketing and Sales Strategy for the Silica Rock Initiative	09/05/16	CI
Earth Life Sciences Inc acquired assets of White Channel Project and Gold Buck Project.	17/02/16	CI
Earth Life Sciences Inc will Change its Ticker to CLTS from CLTS.D	07/07/15	CI
Earth Life Sciences Inc has Changed its Ticker to CLTS.D from CLTS	10/06/15	CI
Earth Life Sciences Inc Appoints Lin Han to the Board of Directors	01/06/15	CI
Canadian Tactical Training Academy Inc. Announces Resignation of Arthur Sapp and Steven Joe as Directors	24/04/14	CI
Canadian Tactical Training Academy Inc. Announces Executive Changes	03/12/12	CI

Chart Earth Life Sciences Inc.

Duration

Period

More charts

Earth Life Sciences Inc. is a Canada-based development stage company. The Company is focused on the transportation software market and digital healthcare services through the mode of online ordering and offline service.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EARTH LIFE SCIENCES INC.	0.00%	999
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+44.05%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.57%	242B
NOVARTIS AG	+13.31%	218B
AMGEN INC.	+8.48%	168B
PFIZER, INC.	-2.81%	159B

Other Pharmaceuticals

Earth Life Sciences Inc.

Equities

CLTS

US27032P2083

Pharmaceuticals

Earth Life Sciences Inc. (OTCPK : CLTS) signed an agreement to acquire VIVA Health, Inc.

Latest news about Earth Life Sciences Inc.

Chart Earth Life Sciences Inc.

Company Profile

Sector Other Pharmaceuticals